2-chloro-n(6)cyclopentyladenosine has been researched along with gw 1929 in 1 studies
Studies (2-chloro-n(6)cyclopentyladenosine) | Trials (2-chloro-n(6)cyclopentyladenosine) | Recent Studies (post-2010) (2-chloro-n(6)cyclopentyladenosine) | Studies (gw 1929) | Trials (gw 1929) | Recent Studies (post-2010) (gw 1929) |
---|---|---|---|---|---|
252 | 0 | 43 | 72 | 0 | 41 |
Protein | Taxonomy | 2-chloro-n(6)cyclopentyladenosine (IC50) | gw 1929 (IC50) |
---|---|---|---|
Cytochrome P450 2C9 | Homo sapiens (human) | 4 | |
Thromboxane-A synthase | Homo sapiens (human) | 2.953 | |
Delta-type opioid receptor | Homo sapiens (human) | 3.209 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, S; Cheong, JH; Jacobson, KA; Jeong, LS; Jin, SH; Kim, G; Kim, HJ; Kim, J; Lee, E; Lee, M; Noh, M; Yu, J | 1 |
1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and gw 1929
Article | Year |
---|---|
Polypharmacology of N
Topics: Adenosine; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Adiponectin; Animals; Cell Line; Diabetes Mellitus, Experimental; Humans; Hypoglycemic Agents; Insulin Resistance; Ligands; Male; Mice; Mice, Inbred C57BL; Polypharmacology; PPAR delta; PPAR gamma; Receptor, Adenosine A3 | 2017 |